|Bid||1.0920 x 250000|
|Ask||1.1350 x 250000|
|Day's Range||1.0920 - 1.0920|
|52 Week Range||0.7520 - 2.4800|
|Beta (3Y Monthly)||2.61|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Alameda, California-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share. The results met Wall Street expectations. The average ...
On a per-share basis, the Alameda, California-based company said it had net income of 53 cents. Losses, adjusted for non-recurring gains, were 7 cents per share. The biotechnology company posted revenue ...
BioTime (BTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioTime (BTX) delivered earnings and revenue surprises of 33.33% and 671.82%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Alameda, California-based company said it had a loss of 3 cents per share. Losses, adjusted for non-recurring gains, were 6 cents per share. The biotechnology company posted revenue of $2.5 million ...
In December 2017, BioTime Inc (AMEX:BTX) released its latest earnings announcement, which signalled tough times for the business, with earnings reversing into losses due to recent headwinds. Below is myRead More...